Drug-Resistant Shigella Surges in Adult Men
Cases of extensively drug-resistant (XDR) Shigella, for which no approved treatment is available, increased significantly between 2011 and 2023, based on data from approximately 17,000 isolates.
Cases of extensively drug-resistant (XDR) Shigella, for which no approved treatment is available, increased significantly between 2011 and 2023, based on data from approximately 17,000 isolates.
As an increasing number of physicians leave private practice to work for hospitals or private equity firms, the risk of conflicts of interest increases.
“A ripple effect from the COVID pandemic may be one reason for the shift in RSV circulation this year, as natural immunity to RSV may have been reduced with mitigation measures that were in place at the time,” said Shirin Mazumder, MD, infectious diseases specialist and associate professor at the University of Tennessee Health Science… Read More
Andrew Wilner is a professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.
A 16-week exercise training program showed broad benefits, including cellular damage repair and slowdown in epigenetic aging, in people with HIV (PWH), based on new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.
Cerebrospinal fluid (CSF) samples from individuals with early HIV infection already showed signs of inflammation compared to samples from individuals without HIV, based on new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.
Underlying herpes infection may have an impact on brain health in people with HIV (PWH), according to new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.
Pritelivir, a new oral therapy, was significantly more effective against herpes simplex virus (HSV) than a comparator treatment for immunocompromised patients with refractory infections, based on data from 101 individuals.